Redeye takes a neutral stance to Lagercrantz following a solid report resulting in increased forecasts and Base case. We believe that the improved margins are here to stay, and rising demand in some areas post-Corona crisis will likely result in further expansion.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Lagercrantz - Solid cost control and optimistic outlook

© Modular Finance, source Nordic Press Releases